Physician

Karen Stewart Jacks, MD

According to 2025 Medicare claims, Karen Jacks, MD (NPI: 1457577470) practices hematology/oncology in the Las Vegas-Henderson-North Las Vegas, NV market, with the plurality of this provider's patient population coming from Clark, NV. This provider's primary affiliated billing organization is ALLISON CURTIS KINGSLEY MEOZ MICHAEL & SANCHEZ PC (NPI: 1598770471; TIN: 88-0350180) and primary practice location at 89148-4861.

Jacks' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 780 traditional Medicare patients, billed 156,373 HCPCS/CPT codes, and received $2,506,016 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,661 prescription claims across 297 beneficiaries totaling $2,154,710 in drug costs, led by Ibrance (Palbociclib). DME data shows 76 claims. Open Payments data shows 120 records totaling $2,726. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $356,665 to $2,154,710. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $5,357 and ending at $7,583.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	479	88,554	$1,294,486
2016	552	124,643	$1,735,622
2017	663	164,947	$2,653,915
2018	737	167,035	$2,863,152
2019	815	204,587	$2,707,537
2020	823	179,216	$2,485,700
2021	773	185,060	$2,534,119
2022	801	157,391	$2,394,859
2023	720	136,094	$2,476,740
2024	780	156,373	$2,506,016

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	150	1,102	$356,665
2016	166	1,135	$614,558
2017	206	1,444	$1,151,216
2018	240	1,524	$874,850
2019	244	1,410	$752,628
2020	259	1,668	$1,121,174
2021	287	1,558	$1,356,448
2022	261	1,461	$1,565,980
2023	272	1,497	$2,155,305
2024	297	1,661	$2,154,710

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	109	$40,603
2016	13	118	$49,137
2017	N/R	74	$21,886
2018	12	152	$21,493
2019	N/R	110	$9,367
2020	N/R	181	$9,693
2021	N/R	176	$9,313
2022	12	178	$9,261
2023	N/R	90	$12,608
2024	N/R	76	$3,010

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	283	642	$100
82378	Carcinoembryonic antigen (cea) protein level	295	751	$19
80053	Blood test, comprehensive group of blood chemicals	399	1,087	$10
36415	Insertion of needle into vein for collection of blood sample	405	972	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	410	1,157	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ibrance	Palbociclib	80	2,205	$1,232,289
Imbruvica	Ibrutinib	14	392	$228,372
Revlimid	Lenalidomide	15	315	$182,992
Eliquis	Apixaban	52	2,460	$47,100
Xarelto	Rivaroxaban	15	1,217	$21,158

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0656	Segmental pneumatic appliance for use with pneumatic compressor, trunk	Y	N/R	24	$1,113
E0657	Segmental pneumatic appliance for use with pneumatic compressor, chest	Y	N/R	24	$1,045
J8521	Capecitabine, oral, 500 mg	N	N/R	16	$701
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	12	$150

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	118	$2,181	Daiichi Sankyo Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	2	$545	Genentech, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Karen Stewart Jacks, MD?

Tedicare shows public-source Medicare data for Karen Stewart Jacks, MD (NPI 1457577470), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Karen Stewart Jacks, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Karen Stewart Jacks, MD?

Karen Stewart Jacks, MD is linked to ALLISON CURTIS KINGSLEY MEOZ MICHAEL & SANCHEZ PC (billing NPI 1598770471) in the available physician profile data.

Does Karen Stewart Jacks, MD have Open Payments data?

Karen Stewart Jacks, MD has 120 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.